Involvement of CD4+ Foxp3+ Regulatory T Cells in Persistence of Leishmania donovani in the Liver of Alymphoplastic aly/aly Mice

Saruda Tiwananthagorn; Kazuya Iwabuchi; Manabu Ato; Tatsuya Sakurai; Hirotomo Kato; Ken Katakura

doi:10.1371/journal.pntd.0001798

Abstract

Visceral leishmaniasis (VL) is a chronic and fatal disease in humans and dogs caused by the intracellular protozoan parasites, Leishmania donovani and L. infantum (L. chagasi). Relapse of disease is frequent in immunocompromised patients, in which the number of VL cases has been increasing recently. The present study is aimed to improve the understanding of mechanisms of L. donovani persistence in immunocompromised conditions using alymphoplastic aly/aly mice. Hepatic parasite burden, granuloma formation and induction of regulatory T cells were determined for up to 7 months after the intravenous inoculation with L. donovani promastigotes. While control aly/+ mice showed a peak of hepatic parasite growth at 4 weeks post infection (WPI) and resolved the infection by 8 WPI, aly/aly mice showed a similar peak in hepatic parasite burden but maintained persistent in the chronic phase of infection, which was associated with delayed and impaired granuloma maturation. Although hepatic CD4⁺Foxp3⁺ but not CD8⁺Foxp3⁺ T cells were first detected at 4 WPI in both strains of mice, the number of CD4⁺Foxp3⁺ T cells was significantly increased in aly/aly mice from 8 WPI. Immunohistochemical analysis demonstrated the presence of Foxp3⁺ T cells in L. donovani–induced hepatic granulomas and perivascular neo-lymphoid aggregates. Quantitative real-time PCR analysis of mature granulomas collected by laser microdissection revealed the correlation of Foxp3 and IL-10 mRNA level. Furthermore, treatment of infected aly/aly mice with anti-CD25 or anti-FR4 mAb resulted in significant reductions in both hepatic Foxp3⁺ cells and parasite burden. Thus, we provide the first evidence that CD4⁺Foxp3⁺ Tregs mediate L. donovani persistence in the liver during VL in immunodeficient murine model, a result that will help to establish new strategies of immunotherapy against this intracellular protozoan pathogen.

Author Summary

The protozoan parasite Leishmania donovani is the causative agent of visceral leishmaniasis (VL) with a variety of outcomes ranging from asymptomatic to fatal infection. In the last decade, an increasing number of VL cases in immunocompromised conditions have been reported. Loss of the control of parasite persistence causes relapse of the disease in these patients. To clarify why parasite persistence and disease are caused in an immunocompromised condition, we examined L. donovani infection in alymphoplastic aly/aly mice that completely lack lymph nodes and have disturbed spleen architecture. Although parasites grew in the liver of aly/+ mice for the first 4 weeks post infection (WPI) and parasites were eliminated by 8 WPI, we found that parasites persisted in the liver of aly/aly mice with the ineffective of granuloma formation to kill the parasites. These aly/aly mice showed significant increases in CD4⁺Foxp3⁺ regulatory T cells in the liver. Consequently, we treated infected mice with anti-CD25 or anti-FR4 mAb to inhibit the function of Tregs, and found significant reductions in both hepatic Foxp3⁺ cells and parasite burden. These results clearly demonstrated for the first time that the expansion of CD4⁺Foxp3⁺ Tregs is involved in hepatic L. donovani persistence in immunodeficient murine model.

Citation: Tiwananthagorn S, Iwabuchi K, Ato M, Sakurai T, Kato H, Katakura K (2012) Involvement of CD4⁺ Foxp3⁺ Regulatory T Cells in Persistence of Leishmania donovani in the Liver of Alymphoplastic aly/aly Mice. PLoS Negl Trop Dis 6(8): e1798. https://doi.org/10.1371/journal.pntd.0001798

Editor: Diane McMahon-Pratt, Yale School of Public Health, United States of America

Received: March 16, 2012; Accepted: July 16, 2012; Published: August 21, 2012

Copyright: © Tiwananthagorn et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: This work was supported in part by the Global COE program, Establishment of International Collaboration Centers for Zoonosis Control (F01, http://www.vetmed.hokudai.ac.jp/gcoe/english/index.html) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Visceral leishmaniasis (VL) is a chronic and fatal disease caused by the intracellular protozoan parasites Leishmania donovani and L. infantum (chagasi), which infect a range of mammalian hosts, including humans, dogs and rodents [1]. Liver, spleen, bone marrow (BM) and lymph nodes are the major sites for parasite growth and disease pathology. Transplantation of infected kidney, liver, heart, lung, pancreas or BM has been shown to cause VL in transplant recipients, indicating lifelong parasite persistence in the viscera [2]. Moreover, malnutrition is a risk factor for the development of VL [3]. Recent experiments in protein energy-, zinc- and iron-deficient mice suggest that this effect is mediated primarily through functional failure of the lymph node barrier and increased early visceralization of the parasites [4]–[6]. Loss of the control of parasite persistence in VL causes the reactivation of parasites and relapse of the disease is frequent in the immunocompromised patients, in which the number of visceral leishmaniasis cases has been increasing recently [7]. However, the mechanisms underlying the parasite persistence in the immunocompromised condition have not been clearly clarified. To develop effective prophylactic or therapeutic strategies against VL, understanding of the precise immune mechanisms including T-cell functions in the chronic stage of infection is required [8].

The role of secondary lymphoid organs for immune responses to Leishmania infection has not been investigated. The aly/aly mouse is an autosomal recessive natural mutant C57BL/6 strain that carries a point mutation within the gene encoding NF-κB inducing kinase (NIK) [9], which prevents the induction of the non-canonical NF-κB pathway [10]. The aly/aly mice lack all lymph nodes and Peyer's patches with the abnormal architecture of spleen and thymus and exhibit severely impaired humoral response [9]. This mutant mouse strain has been used to examine the role of secondary lymphoid organs for immune responses to intracellular pathogens, including Mycobacterium leprae, Listeria monocytogenes, vesicular stomatitis virus, vaccinia virus, lymphocytic choriomeningitis virus and human T-cell leukemia virus [11]–[14], and different susceptibilities to these pathogens have been reported.

Organ-specific immunity has been described in various experimental VL studies in mouse models [15], [16]. The liver is the site of an acute but resolving infection. In contrast, the spleen becomes a site of parasite persistence with associated immunopathological changes [17]. In BALB/c and C57BL/6 mice, the inflammatory granuloma reaction around infected Kupffer cells is developed and the infection is resolved by 4–8 weeks after infection [18]. However, low levels of hepatic parasite persistence for 6–12 additional months occur and administration of anti-CD4 antibodies result in the relapse of hepatic quiescent L donovani infection [19], suggesting that CD4⁺ T cells are required for the maintenance of acquired immunity and prevention of relapse. However, no additional data explaining the underlying mechanisms of CD4⁺ T cell-mediated control of persistent parasites have been presented. Cellular and molecular interactions mediated by Kupffer cells, monocytes, CD4⁺ and CD8⁺ T cells and a number of cytokines and chemokines are required for effective hepatic granuloma formation [16]–[18], [20], [21]. Defects in these cellular and molecular factors cause ineffective parasite clearance from the liver, but most murine studies have focused on the first few weeks of infection and not the persistent stage of infection [18].

The present study is aimed to improve the understanding of mechanisms of L. donovani persistence in an immunocompromised condition. Our data presented herein offered a novel insight into the involvement of CD4⁺Foxp3⁺ regulatory T cells (Tregs) in L. donovani persistence in the liver of immunodeficient aly/aly mice. Moreover, treatment of infected aly/aly mice with anti-CD25 or anti-FR4 mAb revealed the significant reductions in both hepatic Tregs and parasite burden. These results suggest that manipulation of Tregs may provide a promising immumotherapeutic strategy for VL.

Materials and Methods

Mice, Parasites and Infection

Female ALY® NscJcl aly/aly and aly/+ mice of 6–8 weeks of age were purchased from CLEA Japan, Inc. (Tokyo, Japan). Mice were maintained, inoculated and sacrificed within a safety facility of Hokkaido University.

A virulent line of L. donovani (MHOM/SU/62/2S-25M-C2) [22] was maintained by passage of the frozen stabilized parasites in NNN medium containing 5% defibrinated hemolyzed rabbit blood. Then, parasites were consecutively sub-passaged in liquid M199 medium supplemented with 15% heat-inactivated fetal calf serum (HIFCS), 25 mM HEPES and 50 µg/ml gentamycin. The stationary growth phase of subcultures with less than five passages was used for mouse inoculation. Mice were infected by injecting stationary phase promastigotes (5×10⁷) intravenously via the lateral tail vein and were sacrificed at 1, 2, 4, 8, 12, 16 and 28 weeks post infection (WPI). One group of non-infected animals was used as naïve control.

Ethics Statement

This study was carried out under the guidance of the Institute for Laboratory Animal Research (ILAR). All animals were housed in a facility in strict accordance with the recommendations in the Guidelines for the Care and Use of Laboratory Animals of Graduate School of Veterinary Medicine, Hokkaido University, which was based on Fundamental Guidelines for Proper Conduct of Animal Experiment and Related Activities in Academic Research Institutions under the jurisdiction of the Ministry of Education, Culture, Sports, Science and Technology, Japan and approved by the American Association for Accreditation of Laboratory Animal Care (AAALAC) international. The protocol was approved by the Committee on the Ethics of Animal Experiments of Hokkaido University (Permit Number: 10-0009).

Determination of Parasite Burdens by LDU in the Liver and qPCR in Different Tissues

Giemsa-stained impression smears of the liver were prepared and parasite burden was determined as Leishman-Donovan Units (LDU), in which LDU is the number of amastigotes per 1,000 host nuclei, multiplied by the liver weight in gram [23].

Genomic DNA (gDNA) was isolated from different tissues, including liver, spleen, BM, blood, heart, lung, kidney, brain and skin, using the QIAamp® DNA Mini Kit (Qiagen, MA, USA). Real-time quantitative (qPCR) assays were performed on the StepOne™ and the StepOnePlus™ Real-Time PCR Systems (Applied Biosystems, CA, USA), following the manufacturer's instructions. A typical 20-µl reaction mixture contained approximately 100 ng gDNA, 1× SYBR® Premix Ex Taq™ II (Takara, Tokyo, Japan), 0.4 µM each primer (Table S1) and 1× Rox™ Reference Dye. All samples were run in triplicate and underwent an initial 30 sec incubation step at 95°C, followed by 40 cycles of 5 sec at 95°C and 30 sec at 65°C for the Leishmania surface protease gp63 gene or 60°C for the mouse brain-derived neurotrophic factor (mBDNF) gene [24], [25]. The average threshold cycle of amplification (Ct) values was determined, and standard deviation (SD) of all the reaction was analyzed by the software provided with the instrument. The relative amounts of the gp63 gene were then calculated using standard curve method normalized to the amounts of the mBDNF gene.

Histopathological Analysis of Infected Foci in the Liver

The livers were fixed in 10% neutral phosphate-buffered formalin. Paraffin-embedded organs were cut into 4 µm-thick sections, followed by staining with hematoxylin and eosin for light microscopy. For the detection of parasites, liver sections were subjected to indirect immunohistochemical staining using L. infantum-infected dog serum (1∶1000 dilution) [26] and horseradish peroxidase (HRP)-conjugated goat anti-dog IgG heavy and light chain antibody (1∶300; Bethyl Laboratories, TX, USA). Peroxidase was visualized using 3,3′-diaminobenzidine (DAB)-H₂O₂ (Wako, Tokyo, Japan) and the sections were counterstained with Mayer's hematoxylin before dehydration and mounting.

Hepatic immune responses were categorized into (1) “No granuloma”: no inflammation with no mononuclear cell (MNC) around the parasitized Kupffer cells; (2) “Immature granuloma”: less than 10 MNCs around the parasitized Kupffer cells; (3) “Mature granuloma”: epithelioid cells and more than 10 MNCs around the parasitized Kupffer cells; and (4) “Involuting granuloma”: devoid of amastigotes and tissue inflammatory nearly resolved [18], [23]. The number of infected foci with each tissue response including “No granuloma”, “Immature granuloma”, “Mature granuloma” and “Involuting granuloma” was counted for 25 consecutive microscopic fields per mouse liver at ×400 magnification.

Determination of Foxp3-expressing T Cells by Flow Cytometry

Hepatic mononuclear cells were isolated using a 33% (vol/vol) Percoll solution, as described elsewhere [27]. Briefly, livers were minced, pressed through a stainless steel mesh and suspended in RPMI1640 medium (Sigma, MO, USA) supplemented with 3% HIFCS (wash buffer). After washing, the cells were resuspended in 33% Percoll solution containing heparin (100 U/ml) and centrifuged at 800× g for 30 min to remove liver parenchymal cells. The pellet was treated with an RBC lysis solution (155 mM NH₄Cl, 10 mM KHCO₃, 0.1 mM EDTA), washed and re-suspended in 2.4G2 mAb solution to block the Fc receptor before staining with antibody. Antibodies used for FACS included PE-labeled rat anti-mouse CD4 (L3T4) (BD Pharmingen, CA, USA), FITC-labeled rat anti-mouse CD8a (Lyt-2) (BD Pharmingen), APC-labeled rat anti-mouse Foxp3 (FJK-16s) (eBioscience, CA, USA) and the proper isotype staining control, according to the manufacturer's instructions. Flow cytometry analysis of the labeled cells was performed on a FACS Calibur (BD Pharmingen), running the Cell Quest program provided with the instrument. Lymphocytes were identified by forward scatter (FSC) and side scatter (SSC) characteristics, gated and further analyzed with Cell Quest software (BD Pharmingen) or FlowJo software V. 5.7.2 (Tree Star Inc., OR, USA).

Determination of Foxp3-expressing Cells and T Cells by Immunohistochemistry

Immunohistochemical analysis of the 4 µm-thick paraffin-embedded sections of the liver was performed to determine the localization of Foxp3⁺ Tregs. After deparaffinization and rehydration, heat-induced epitope retrieval (HIER) was conducted by autoclaving at 100°C for 17 min using Target Retrieval Solution (pH 9.0) (Dako, Uppsala, Sweden). Endogenous peroxidase was blocked by incubating sections in 0.3% H₂O₂ in absolute methanol for 30 min at 4°C, followed by flushing with water and incubation with 10% goat serum for 1 h at room temperature (RT) to block crystallized receptor fragments. The sections were incubated overnight with rat anti-mouse/rat Foxp3 mAb, clone FJK-16s (eBioscience), in 1∶100 diluted with 0.1% Triton X in PBS (pH 7.4). For negative control sections, PBS was used instead of the primary antibody. After washing three times in PBS (5 min each), sections were incubated in 1∶100 biotin-conjugated goat anti-rat IgG (H+L) antibody (Invitrogen, MD, USA) for 30 min at RT. Sections were then washed, which was followed by incubation with streptavidin-peroxidase conjugate (Histofine SAB-PO® Kit) for 30 min at RT. The streptavidin-biotin complex was visualized with DAB-H₂O₂ solution, pH 7.0, for 4 min. Sections were washed in distilled water, and finally counterstained with Mayer's hematoxylin. The mean counts of Foxp3-expressing cells were assessed microscopically at 400× magnification by counting a total of 25 consecutive fields. The number of immunoreactive cells was estimated in each hepatic granuloma assembly. Values are expressed as the means of immunoreactive cells present in 25 fields.

Double Immunofluorescence Analysis

Double immunofluorescence staining was also conducted to locate Tregs in the liver. Formalin-fixed and paraffin-embedded liver sections were subjected to the deparaffinization, rehydration and HIER as described above. After blocking of crystallized receptor fragments with 10% goat serum, sections were incubated overnight with rat anti-mouse/rat Foxp3 mAb (clone FJK-16s; 1∶100; eBioscience) at 4°C. Then, the sections were incubated with FITC-goat anti rat IgG (1∶200; Zymed, CA, USA) for 30 min at RT and successively incubated in 10% donkey or rabbit serum to block the crystallized receptor fragments. For double staining of Foxp3-expressing cells and T cells, the sections were incubated with rabbit anti-mouse CD3 mAb (1∶200; Nichirei) overnight at 4°C and then with TRITC-donkey anti rabbit IgG (1∶200; Abcam, MA, USA) for 30 min at RT. On the other hand, double staining of Foxp3-expressing cells and L. donovani amastigotes was conducted using L. infantum-infected dog serum (1∶1,000) and TRITC-goat anti dog IgG (1∶200; Rockland, PA, USA). Finally, the sections were mounted using a Fluoromount™ (DBS, CA, USA) and examined under an IX70 confocal microscope (Olympus, Tokyo, Japan).

Laser Microdissection, RNA Purification and qRT-PCR

Laser microdissection (LMD) was performed in RNase-free conditions as described previously [28]. Cryosections of 7 µm thickness were prepared from the frozen livers of naïve and infected mice and embedded in Tissue-Tek OTC compound (Sakura, Tokyo. Japan). The sections were mounted on glass slides pre-coated with LMD films (Meiwafosis, Osaka, Japan) and fixed with absolute methanol for 3 min at 4°C. After staining with 0.5% toluidine blue for 10 sec, approximately 20 “Mature granulomas” were microdissected from each frozen liver sample by using Ls-Pro300 (Meiwafosis).

Total RNA was purified from the frozen whole liver tissue and microdissected “Mature granulomas”, using the RNAqueous®-Micro Kit (Ambion, Texas, USA). Expression levels of Foxp3, TGF-β and IL-10 mRNA were determined by quantitative RT-PCR (qRT-PCR) using the PrimeScript™ RT Reagent Kit (Takara) and the relative number of these molecules to 1000 housekeeping glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was calculated using a standard curve method. The PCR reaction was performed as described above using primers shown in Table S1 [29], [30].

Inhibition of CD4⁺ Foxp3⁺ Treg Function

At 26 WPI, three L. donovani-infected aly/aly mice were intraperitoneally injected three times every other day with 0.5 mg of rat anti-mouse CD25 mAb (clone PC61; Biolegend, CA, USA), 0.05 mg of rat anti-mouse FR4 mAb (clone TH6; Biolegend) or 0.5 mg of rat IgG (Jackson ImmunoResearch, PA, USA) as a control. The mice were euthanized at 10 days post-antibody injection for examination of host responses as described above.

Statistics

Statistical differences between aly/aly mice and aly/+ mice at the indicated time points were tested using Student's t-test (Microsoft Excel software) and two-way ANOVA as well as post hoc Bonferroni test (Prism software version 5, GraphPad, CA, USA). All data are presented as the mean values ± SE unless otherwise stated. p<0.05 was considered as statistically significant.

Results

Long-term Persistence of L. donovani in the Liver of aly/aly Mice

Long-term persistence after clinical cure of the primary infection is a characteristic feature of many intracellular pathogens, including protozoan parasites of the genus Leishmania, but the underlying mechanisms are not fully understood [31]. We measured parasite burdens in the livers of aly/+ and aly/aly mice for up to 28 WPI by two different methods. The number of amastigotes in hepatic impression smears was expressed as LDU (Figure 1A), and relative amounts of Leishmania gp63 gene to mBDNF gene were determined by qPCR (Figure 1B). In aly/+ mice, parasite burden peaked at 4 WPI and reduced to near-baseline levels by 8 WPI. In aly/aly mice, parasite burden also peaked at 4 WPI but the maximum parasite burden was lower than that of aly/+ mice. Although the parasite load decreased by 8 WPI as observed in aly/+ mice, the parasite persisted in the liver of aly/aly mice during the observation period of 28 WPI (Figure 1). Persistent L. donovani infection was also demonstrated in the spleen and BM of both mice strains but the parasite burden was much higher in aly/aly mice during the chronic phase of infection. Nevertheless, parasite was not detected in the skin and internal organs, such as lung, kidney, heart and brain during infection by qPCR (data not shown).

Download:

Figure 1. Long-term persistence of L. donovani amastigotes in the liver of aly/aly mice.

Promastigotes of L. donovani were intravenously inoculated into aly/+ (○) and aly/aly (•) mice, and at the indicated time points, parasite burdens in the liver were determined as LDU (A), and relative amounts of Leishmania gp63 gene to mouse housekeeping BDNF gene by qPCR (B). A typical result of two individual experiments is shown. Data are the mean ± SE for three mice of each strain. * p<0.05; ** p<0.01.

https://doi.org/10.1371/journal.pntd.0001798.g001

Delayed and Impaired Hepatic Granuloma Maturation in aly/aly Mice During L. donovani Infection

Efficient granuloma development around infected Kupffer cells is a key event in the control of hepatic L. donovani infection [8], [16], [18]. The infected foci in the liver were examined and made a quantitative analysis of granuloma formation around the parasitized Kupffer cells. The progression of granuloma formation from “No granuloma” to “Immature granuloma”, “Mature granuloma” and finally “Involuting granuloma” was observed in aly/aly mice as well as aly/+ mice (Figure S1), indicating that aly/aly mice have ability to generate hepatic cell-mediated immunity to some extent as shown in the previous study [32].

The number of infected foci was well correlated with the hepatic parasite loads (Figure 1); the number of foci in aly/+ mice reached a peak at 4 WPI and was drastically reduced at 8 WPI (Figure 2A) and the involuting granuloma was well formed (Figure 2B). However, the number of involuting granuloma in the liver of aly/aly mice were much less than those in aly/+ mice at 4 and 8 WPI (Figure 2C) while the 30–40% of the infection foci with no granulomas was found in the liver of aly/aly mice at 4–16 WPI. These may reflect that effective but insufficient clearance of the parasites in granuloma of aly/aly livers renders persistent release of the parasites, which results in increased proportion of infected Kupffer cells in the later stages.

Download:

Figure 2. Delayed and impaired hepatic granuloma maturation in aly/aly mice during L. donovani infection.

Host immune responses to each infected focus were quantitatively analyzed in aly/+ (open bars) and aly/aly (filled bars) mice during the course of L. donovani infection. Total number of infected foci was counted from 25 consecutive microscopic fields (A). The proportion of “No granuloma”, “Immature granulomas”, “Mature granulomas” and “Involuting granuloma” of aly/+ (B) and aly/aly (C) mice are estimated. A typical result of two individual experiments is shown. Data are the mean ± SE for three mice of each strain. ND, not determined; * p<0.05; ** p<0.01.

https://doi.org/10.1371/journal.pntd.0001798.g002

Expansion of CD4⁺Foxp3⁺ Tregs in the Liver of aly/aly Mice During Persistent L. donovani Infection

Foxp3⁺ Tregs influence immunity to viral, bacterial or parasitic infections [33]. To begin to characterize the mechanism by which parasites persist in the liver, we examined whether Tregs expand in the livers of aly/aly mice and where they localize during L. donovani infection.

Flow cytometry analysis of hepatic lymphocytes revealed no expansion of CD8⁺Foxp3⁺ T cells in the liver during L. donovani infection in either strain of mice (Figure 3A). In contrast, CD4⁺Foxp3⁺ T cells were first detected at 4 WPI in both strains of mice. In aly/aly mice, the proportions of CD4⁺Foxp3⁺ T cells to CD4⁺ T cells (Figure. 3B) as well as the absolute number of CD4⁺Foxp3⁺ T cells (Figure 3C) were higher than those of aly/+mice especially at 8–16 WPI although the total number of hepatic CD4⁺ T cells was not significantly different between aly/+ and aly/aly mice (Figure S2).

Download:

Figure 3. Expansion of CD4⁺Foxp3⁺ Tregs in the liver of aly/aly mice during persistent L. donovani infection.

Flow cytometry analysis of CD4⁺Foxp3⁺ and CD8⁺Foxp3⁺ Tregs among the hepatic lymphocytes. (A) Representative data of the gated lymphocytes extracted from the liver at 12 WPI of aly/+ (left) and aly/aly mice (right), stained with anti-Foxp3 and anti-CD4 or anti-CD8 mAb. (B) The proportion of CD4⁺Foxp3⁺ T cells to CD4⁺ T cells in aly/+ (open bars) and aly/aly (filled bars) mice. (C) The total number of CD4⁺Foxp3⁺ T cells in aly/+ (open bars) and aly/aly (filled bars) mice at 8–16 WPI. A typical result of two individual experiments is shown. Data are the mean ± SE for three mice of each strain. ND, not determined; * p<0.05; *** p<0.001.

https://doi.org/10.1371/journal.pntd.0001798.g003

Presence of Foxp3⁺ Tregs Inside Granulomas and Perivascular Neo-lymphoid Areas in the L. donovani-infected liver of aly/aly Mice

There have been no reports describing the localization of Foxp3-expressing cells in the liver during VL. To address this, we stained Foxp3 in liver sections of naïve and L. donovani-infected aly/+ and aly/aly mice. Foxp3-expressing cells were localized in the “Immature granuloma” and “Mature granulomas” as well as the perivascular areas of infected aly/aly mice. Furthermore, the density of Tregs increased, especially in the perivascular areas, during the course of infection (Figure 4A and B). Development of such abnormal lymphocyte infiltration or neo-lymphoid aggregates at perivascular areas is a feature found in aly/aly and other alymphoplastic mice [32]. In addition, the frequency of “Mature granulomas” containing more than 5 Tregs increased during infection in aly/aly mice (5% at 4 WPI, 18% at 12 WPI and 39% at 28 WPI), suggesting the accumulation of Tregs at sites of inflammatory foci. On the other hand, Foxp3-positive Tregs were limited to the parenchyma, granulomas and perivascular areas at 4 WPI and hardly detectable in the liver of infected aly/+ mice at 12 WPI (Figure 4A and B).

Download:

Figure 4. Presence of Foxp3⁺ Tregs inside granulomas in the liver of L. donovani-infected aly/aly mice.

Localization of Foxp3-expressing cells in liver sections from aly/+ mice and aly/aly mice during the course of L. donovani infection was analyzed by immunohistochemistry using anti-Foxp3 mAb. Typical reactions in the liver parenchyma including “Immature granuloma” and “Mature granulomas” (A) and perivascular areas (B) in uninfected naïve mice and infected mice at 4 and 12 WPI are shown. The brown pigments represent Foxp3-immunoreactive cells.

https://doi.org/10.1371/journal.pntd.0001798.g004

Double immunofluorescence analysis of hepatic granuloma revealed that Foxp3-expressing cells (green in Figure 5A) and CD3⁺ cells (red in Figure 5A) were present in the granuloma, and Foxp3⁺ cells expressed CD3 molecules (Figure 5A-merged image). Some CD3⁺Foxp3⁺ cells (yellow arrows in Figure 5A-merged image) were adjacent to the CD3⁺Foxp3⁻ cells (pink arrows in Figure 5A-merged image). In addition, L. donovani amastigotes (red in Figure 5B) were surrounded by Foxp3⁺ cells (green in Figure 5B) in the hepatic granuloma. These results suggested that the interaction among parasitized cells (Kupffer cells), CD3⁺Foxp3⁺ cell (Tregs) and CD3⁺Foxp3⁻ cells (non Tregs, probably CD4⁺ and/or CD8⁺ effector T cells).

Download:

Figure 5. Localization of Foxp3-expressing cells in L. donovani-infected granuloma of aly/aly mice.

Representative “Mature granuloma” in the liver sections of aly/aly mice at 12 WPI using single and double immunostaining. (A) Foxp3⁺ cells (green; upper left), CD3⁺cells (red; upper right) and a merged image (lower) showed CD3⁺Foxp3⁺ (yellow arrows) and CD3⁺Foxp3⁻ (pink arrows) cells. (B) Foxp3⁺ cells (green; upper left), Leishmania amastigotes (red; upper right) and a merged image (lower). Arrows indicated the positive stained cells.

https://doi.org/10.1371/journal.pntd.0001798.g005

Association of Foxp3 and IL-10 mRNA Expression in “Mature Granulomas”

Evidence has accumulated regarding the essential roles of Tregs in the control of a variety of physiological and pathological immune responses, but it is still obscure how Tregs control other lymphocytes at the molecular level [34]. Quantitative RT-PCR was performed for Foxp3, IL-10 and TGF-β mRNA levels in the whole liver and micro-dissected “Mature granulomas” liver tissue samples of L. donovani-infected aly/aly mice. The Foxp3 mRNA expression was increased after infection in the whole liver (Figure 6A) and mature granuloma samples (Figure 6B). Although the TGF-β mRNA transcripts showed similar levels at 4 and 12 WPI in both tissue samples, the levels of IL-10 mRNA markedly increased in mature granuloma but not whole liver samples at 12 WPI (Figure 6A and B), suggesting that IL-10 may be involved in function of Tregs.

Download:

Figure 6. Expression of Foxp3, TGF-β and IL-10 mRNAs in the liver of L. donovani-infected aly/aly mice.

Relative mRNA levels of Foxp3, IL-10 and TGF-β to 1000 GAPDH were estimated in the whole liver samples (A) and microdissected hepatic parenchymal or granuloma tissue samples (B) of naïve (0 WPI) and L. donovani infected aly/aly mice at 4 and 12 WPI. A typical result of two individual experiments is shown. Data are the mean ± SE for three mice at each indicating time point.

https://doi.org/10.1371/journal.pntd.0001798.g006

Enhanced Effector Immune Responses and Declined Parasite Burden in the Liver After Inhibition of Treg Function in L. donovani-infected aly/aly Mice

Manipulation of Tregs by treatment with antibodies has been used to examine the roles of Tregs in many infectious diseases [33]. Effects of anti-CD25 and anti-FR4 mAb on hepatic immune responses in L. donovani-infected aly/aly mice at 26 WPI were examined. Ten days after injection with anti-CD25 or anti-FR4, reduction in Foxp3 mRNA expression was observed (Figure 7A). This reduced Foxp3 mRNA expression was associated with decreases in parasite burden (Figure 7B) and infected foci (Figure 7C). Instead, the frequency of “Mature granulomas” was increased after treatment with especially anti-FR4 mAb (Figure 7D), suggesting that depletion of Tregs can activate hepatic cellular immune responses and accelerate parasite killing. Furthermore, immunohistochemical analysis confirmed a reduction in Foxp3-immunoreactive cells in the liver parenchyma, granulomas (Figure 7E) and perivascular neo-lymphoid areas (data not shown).

Download:

Figure 7. Effects of anti-Treg antibodies on Foxp3 expression, parasite burden and infected foci in the liver.

The L. donovani-infected aly/aly mice were intraperitoneally injected with anti-CD25 or anti-FR4 mAb at 26 WPI and hepatic immune responses were examined after 10 days of injection. (A) Foxp3 mRNA expression by RT-PCR. (B) Parasite burden expressed by qPCR. (C) The number of infected foci from 25 consecutive microscopic fields. (D) Frequency of mature (black column) and immature (grey column) granuloma, and no response (white column) in the infected foci. (E) Localization of Foxp3-stained cells in the liver parenchyma including “Immature granulomas” and “Mature granulomas”. The brown pigments represent Foxp3-immunoreactive cells. * p<0.05; *** p<0.001.

https://doi.org/10.1371/journal.pntd.0001798.g007

Discussion

In the present study, aly/aly mice were used as an immunodeficient VL murine model and immunohistopathologically investigated during L. donovani infection for up to 28 WPI. CD4⁺Foxp3⁺ T cells were increased in the granulomas and perivascular areas of the liver in the chronic phase and the impairment of granuloma maturation was observed. The depletion of Tregs by the administration of either anti-CD25 or anti-FR4 mAb resulted in significant reductions in hepatic Tregs, infected foci and parasite burden. To our knowledge, this is the first definitive evidence that CD4⁺Foxp3⁺ Tregs are involved in hepatic L. donovani persistence in a murine model of VL.

The aly/aly mice have been used to examine the role of secondary lymphoid organs on immune responses in various infection models. Disruptive architecture of the thymus and spleen could affect the development and expansion of T cells. Several studies using bone marrow chimeras between aly/aly and wild type mice showed that antiviral CTL responses were clearly improved in the wild type environment [11]. However, expansion of CD25⁺CD4⁺ Treg is impaired in the spleen of aly/aly mice [35]. This suggests that expansion of functional CD4⁺Foxp3⁺ Treg in the liver of aly/aly mice during L. donovani infection is likely related to the parasite persistence but not to the structural defects of secondary lymphoid organs although this possibility will be confirmed by BM chimera experiments in future.

The NIK gene mutation may contribute to other immune defects due to the partial blocked NF-κB activation [10], [36]. NF-κBp52 knockout mice showed less parasite burden in the liver, perhaps due to less number of B cells (unpublished data; Ato M., Kaye PM). NF-κBp50 (NF-κB1) would be important for TNF/TLR signaling which is involved in canonical TLR/TNFR signaling for activation of dendritic cells and macrophages. NIK is associated in CD40/LT-αβR but not in TNF. CD40 signaling is one of DC activation factors, but the function of DC of aly/aly are controversial. Yamada et al [36] has reported that DC from aly/aly mice exhibit grossly normal development and function. However, Tamura et al [35] had reported that DCs from aly/aly mice showed impaired antigen presentation ability. Lower hepatic parasite loads was unexpectedly observed in aly/aly mice than aly/+ mice in the first 4 WPI. This may be not due to lower number of the sessile Kupffer cells (unpublished data), but associated with the strong innate immunity as reported during Listeria monocytogenes infection in aly/aly mice [12]. Partial hepatic granuloma progression and neo-lymphoid aggregates in aly/aly mice imply that mice lacking secondary lymphoid tissues can still generate T cell-mediated immune responses to some extent [32].

Although anti-CD25 mAbs have been used for depletion of Tregs in various experimental cases, administration of anti-FR4 mAb also reduced Treg numbers and provoked effective tumor immunity [37]–[39]. In the present study, 10 days after the third injection of infected aly/aly mice with anti-CD25 and anti-FR4 mAb, the hepatic parasite burdens were reduced by 88% and 89% of that of control mice, respectively (Figure 7B). Likewise, treatment with either anti-CD25 or anti-FR4 mAb also reduced parasite burdens in the spleen and BM (Figure S3). The reason why anti-FR4 mAb was more effective than anti-CD25 mAb in reducing parasite burden is unknown, but the present study is the first to report effectiveness of anti-FR4 mAb to control systemic infection of L. donovani in mice. Thus, anti-FR4 antibodies may be an alternative measure to manipulate Tregs in chronic VL. However, since anti-CD25 mAb can also affect effector T cells and effective immunity [39], and anti-FR4 mAb can also deplete a small population of CD4⁺ Foxp3⁻ T cells in the lymph node [38], probably including IL-10-producing conventional CD4⁺ T cells, further studies of the role of Tregs in VL are required.

Studies of Tregs in cutaneous leishmaniasis demonstrated the involvement of CD4⁺CD25⁺ Tregs in cutaneous leishmaniasis caused by L. major [40], [41] and L. amazonensis in mice [42] and by L. braziliensis in humans [43]. Regarding VL, the role of Tregs is uncertain and the primary source of IL-10 is controversial. In the spleen of VL patients in India, CD4⁺CD25⁻Foxp3⁻ cells were identified as the major producers of IL-10 [44]. In L. infantum-infected BALB/c mice, CD4⁺CD25⁺ Foxp3⁺ cells expanded in a pooled fraction of draining lymph nodes and spleen cells at 7 and 28 days of infection [45]. In L. donovani-infected BALB/c mice, the number of splenic CD4⁺ CD127^dimCD25⁺GITR⁺ T cells expressing higher Foxp3 and IL-10 increased at 21 days of infection [46]. IL-10 production by splenic CD4⁺CD25⁻Foxp3⁻ IL10⁺ T cells, representing type 1 regulatory T (Tr1) cells, was a strong correlate of disease progression in L. donovani-infected C57BL/6 mice [47]. Further analyses using quantitative RT-PCR of IL-10 and Foxp3 transcripts in selected populations of CD25⁺ and CD25⁻ enriched hepatic CD4⁺ T cells, and/or by intracellular cytokine staining, will elucidate the issue. Nevertheless, in the present study, Treg and IL-10 augment immunosuppressive effects in hepatic granuloma of L. donovani-infected aly/aly mice. Maintenance of relatively higher expression levels of TGF-β in the chronic phase of the infection in aly/aly mice may be related to the generation and maintenance of CD4⁺Foxp3⁺ Tregs [48] rather than the inhibition of granuloma maturation [49].

In conclusion, we focused on immune responses to the chronic phase of murine VL caused by L. donovani infection in an immunodeficient host. In the last decade when the number of visceral leishmaniasis in immunocompromised patients has been increasing, our data presented herein offered a novel insight into the possibly involvement of CD4⁺Foxp3⁺ Tregs in persistent L. donovani infection in the liver of immunodeficient hosts. The manipulation of Tregs may provide a promising immumotherapeutic strategy for VL.

Supporting Information

Figure S1.

Hepatic immune response and granuloma formation in aly/+ and aly/aly mice 2–8 weeks after L. donovani infection. Representative hepatic immune responses to infected foci in liver sections by staining with HE and immunostaining with anti-Leishmania serum for aly/+ (A–D and E–H, respectively) and aly/aly (I–L and M–P, respectively) mice are shown. Immune responses to parasitized Kupffer cells were categorized into four types; “No granuloma” (A and E, I and M), “Immature granuloma” (B and F, J and N), “Mature granuloma” (C and G, K and O) and “Involuting granuloma” (D and H, L and P). The brown pigments indicate L. donovani amastigotes. The yellow circles indicate L. donovani-infected foci in each type of tissue responses.

https://doi.org/10.1371/journal.pntd.0001798.s001

(PDF)

Figure S2.

Proportion of CD4⁺Foxp3⁺ and CD4⁺ T cells to gated hepatic lymphocytes during the course of L. donovani infection by flow cytometry analysis. Hepatic lymphocytes were isolated from the liver of aly/+ and aly/aly mice at indicated time points after L. donovani infection and stained with anti-CD4, CD8 and Foxp3 antibodies. Percentage of CD4⁺ T cells (white bars) and CD4⁺Foxp3⁺ T cells (black bars) of aly/+ (A) and aly/aly mice (B) are shown.

https://doi.org/10.1371/journal.pntd.0001798.s002

(PDF)

Figure S3.

Effects of anti-Treg antibody treatment on parasite burden in the spleen and bone marrow. The L. donovani-infected aly/aly mice were intraperitoneally injected with anti-CD25 or anti-FR4 mAb at 26 WPI, and parasite burden in the spleen (A) and bone marrow (B) was estimated by qPCR after 10 days of antibody treatment. * p<0.05; ** p<0.01.

https://doi.org/10.1371/journal.pntd.0001798.s003

(PDF)

Table S1.

Target genes and primers for qPCR and RT-PCR used in this study.

https://doi.org/10.1371/journal.pntd.0001798.s004

(DOCX)

Acknowledgments

We thank Dr. Christian Engwerda, Immunology and Infection Laboratory, Queensland Institute of Medical Research, Australia, for beneficial suggestions and discussion. We would also like to thank Drs. Osamu Ichii, Yasuhiro Kon, Saori Otsuka, Yoshinori Ikenaka, Nobuya Sasaki, Takashi Agui, Kazuhiko Ohashi, Kenji Ochiai and Mrs. Kozue Miyashita, Graduate School of Veterinary Medicine, Hokkaido University, Japan, for immunological and immunohistochemical analysis.

Author Contributions

Conceived and designed the experiments: ST KI MA TS KK. Performed the experiments: ST KI KK. Analyzed the data: ST KI MA HK. Wrote the paper: ST KI MA HK KK.

References

1. Saridomichelakis MN (2009) Advances in the pathogenesis of canine leishmaniosis: epidemiologic and diagnostic implications. Vet Dermatol 20: 471–489.
- View Article
- Google Scholar
2. Antinori S, Cascio A, Parravicini C, Bianchi R, Corbellino M (2008) Leishmaniasis among organ transplant recipients. Lancet Infect Dis 8: 191–199.
- View Article
- Google Scholar
3. Desjeux P (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27: 305–318.
- View Article
- Google Scholar
4. WHO (2010) Control of the Leishmaniases: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22–26 March 2010.186pp.
5. Anstead GM, Chandrasekar B, Zhao W, Yang J, Perez LE, et al. (2001) Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection. Infect Immun 69: 4709–4718.
- View Article
- Google Scholar
6. Malafaia G (2009) Protein-energy malnutrition as a risk factor for visceral leishmaniasis: a review. Parasite Immunol 31: 587–596.
- View Article
- Google Scholar
7. Fernández-Guerrero ML, Robles P, Rivas P, Mójer F, Muñíz G, et al. (2004) Visceral leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosis. Acta Trop 90: 11–16.
- View Article
- Google Scholar
8. Kaye PM, Svensson M, Ato M, Maroof A, Polley R, et al. (2004) The immunopathology of experimental visceral leishmaniasis. Immunol Rev 201: 239–253.
- View Article
- Google Scholar
9. Miyawaki S, Nakamura Y, Suzuka H, Koba M, Yasumizu R, et al. (1994) A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice. Eur J Immunol 24: 429–434.
- View Article
- Google Scholar
10. Shinkura R, Kitada K, Matsuda F, Tashiro K, Ikuta K, et al. (1999) Alymphoplasia is caused by a point mutation in the mouse gene encoding NF-kappa B-inducing kinase. Nat Genet 22: 74–77.
- View Article
- Google Scholar
11. Karrer U, Althage A, Odermatt B, Roberts CW, Korsmeyer SJ, et al. (1997) On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hox11(−)/−) mutant mice. J Exp Med 185: 2157–2170.
- View Article
- Google Scholar
12. Nishikawa S, Nakane A (1998) Host resistance against Listeria monocytogenes is reciprocal during the course of infection in alymphoplastic aly mutant mice. Cell Immunol 187: 88–94.
- View Article
- Google Scholar
13. Yogi Y, Endoh M, Banba T, Okamura H, Nomaguchi H (1998) Susceptibility to Mycobacterium leprae of ALY (alymphoplasia) mice and IFN-gamma induction in the culture supernatant of spleen cells. Int J Lepr Other Mycobact Dis 66: 464–474.
- View Article
- Google Scholar
14. Nitta T, Tanaka M, Sun B, Sugihara E, Kimura M, et al. (2008) Reduction of human T-cell leukemia virus type-1 infection in mice lacking nuclear factor-kappaB-inducing kinase. Cancer Sci 99: 872–878.
- View Article
- Google Scholar
15. Engwerda CR, Ato M, Kaye PM (2004) Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis. Trends Parasitol 20: 524–530.
- View Article
- Google Scholar
16. Engwerda CR, Kaye PM (2000) Organ-specific immune responses associated with infectious disease. Immunol Today 21: 73–78.
- View Article
- Google Scholar
17. Stanley AC, Engwerda CR (2007) Balancing immunity and pathology in visceral leishmaniasis. Immunol Cell Biol 85: 138–147.
- View Article
- Google Scholar
18. Murray HW (2001) Tissue granuloma structure-function in experimental visceral leishmaniasis. Int J Exp Pathol 82: 249–267.
- View Article
- Google Scholar
19. Murray HW, Hariprashad J, Fichtl RE (1996) Models of relapse of experimental visceral leishmaniasis. J Infect Dis 173: 1041–1043.
- View Article
- Google Scholar
20. Murray HW, Squires KE, Miralles CD, Stoeckle MY, Granger AM, et al. (1992) Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity. J Immunol 148: 1858–1863.
- View Article
- Google Scholar
21. Oghumu S, Lezama-Dávila CM, Isaac-Márquez AP, Satoskar AR (2010) Role of chemokines in regulation of immunity against leishmaniasis. Exp Parasitol 126: 389–396.
- View Article
- Google Scholar
22. Katakura K, Kobayashi A (1988) Acid phosphatase activity of virulent and avirulent clones of Leishmania donovani promastigotes. Infect Immun 56: 2856–2860.
- View Article
- Google Scholar
23. Engwerda CR, Ato M, Stäger S, Alexander CE, Stanley AC, et al. (2004) Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection. Am J Pathol 165: 2123–2133.
- View Article
- Google Scholar
24. Bretagne S, Durand R, Olivi M, Garin JF, Sulahian A, et al. (2001) Real-time PCR as a new tool for quantifying Leishmania infantum in liver in infected mice. Clin Diagn Lab Immunol 8: 828–831.
- View Article
- Google Scholar
25. Tupperwar N, Vineeth V, Rath S, Vaidya T (2008) Development of a real-time polymerase chain reaction assay for the quantification of Leishmania species and the monitoring of systemic distribution of the pathogen. Diagn Microbiol Infect Dis 61: 23–30.
- View Article
- Google Scholar
26. Kawamura Y, Yoshikawa I, Katakura K (2010) Imported leishmaniasis in dogs, US military bases, Japan. Emerg Infect Dis 16: 2017–2019.
- View Article
- Google Scholar
27. Watarai H, Nakagawa R, Omori-Miyake M, Dashtsoodol N, Taniguchi M (2008) Methods for detection, isolation and culture of mouse and human invariant NKT cells. Nat Protoc 3: 70–78.
- View Article
- Google Scholar
28. Ichii O, Kamikawa A, Otsuka S, Hashimoto Y, Sasaki N, et al. (2010) Overexpression of interferon-activated gene 202 (Ifi202) correlates with the progression of autoimmune glomerulonephritis associated with the MRL chromosome 1. Lupus 19: 897–905.
- View Article
- Google Scholar
29. Overbergh L, Giulietti A, Valckx D, Decallonne R, Bouillon R, et al. (2003) The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 14: 33–43.
- View Article
- Google Scholar
30. Hori S, Takahashi T, Sakaguchi S (2003) Control of autoimmunity by naturally arising regulatory CD4⁺ T cells. Adv Immunol 81: 331–371.
- View Article
- Google Scholar
31. Bogdan C (2008) Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example. Cell Microbiol 10: 1221–1234.
- View Article
- Google Scholar
32. Greter M, Hofmann J, Becher B (2009) Neo-lymphoid aggregates in the adult liver can initiate potent cell-mediated immunity. PLoS Biol 7: e1000109.
- View Article
- Google Scholar
33. Belkaid Y (2007) Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol 7: 875–888.
- View Article
- Google Scholar
34. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T (2009) Regulatory T cells: how do they suppress immune responses? Int Immunol 21: 1105–1111.
- View Article
- Google Scholar
35. Tamura C, Nakazawa M, Kasahara M, Hotta C, Yoshinari M, et al. (2006) Impaired function of dendritic cells in alymphoplasia (aly/aly) mice for expansion of CD25⁺CD4⁺ regulatory T cells. Autoimmunity 39: 445–453.
- View Article
- Google Scholar
36. Yamada T, Mitani T, Yorita K, Uchida D, Matsushima A, et al. (2000) Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-kappa B-inducing kinase. J Immunol 165: 804–812.
- View Article
- Google Scholar
37. Li Y, Liu S, Margolin K, Hwu P (2009) Summary of the primer on tumor immunology and the biological therapy of cancer. J Transl Med 7: 11.
- View Article
- Google Scholar
38. Teng MWL, Swann JB, von Scheidt B, Sharkey J, Zerafa N, et al. (2010) Multiple antitumor mechanisms downstream of prophylactic regulatory T-cell depletion. Cancer Res 70: 2665–2674.
- View Article
- Google Scholar
39. Yamaguchi T, Hirota K, Nagahama K, Ohkawa K, Takahashi T, et al. (2007) Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity 27: 145–159.
- View Article
- Google Scholar
40. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL (2002) CD4⁺CD25⁺ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502–507.
- View Article
- Google Scholar
41. Belkaid Y (2003) The role of CD4(+)CD25(+) regulatory T cells in Leishmania infection. Expert Opin Biol Ther 3: 875–885.
- View Article
- Google Scholar
42. Ji J, Masterson J, Sun J, Soong L (2005) CD4⁺CD25⁺ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection. J Immunol 174: 7147–7153.
- View Article
- Google Scholar
43. Campanelli AP, Roselino AM, Cavassani KA, Pereira MS, Mortara RA, et al. (2006) CD4⁺CD25⁺ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J Infect Dis 193: 1313–1322.
- View Article
- Google Scholar
44. Nylén S, Maurya R, Eidsmo L, Manandhar KD, Sundar S, et al. (2007) Splenic accumulation of IL-10 mRNA in T cells distinct from CD4⁺CD25⁺ (Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med 204: 805–817.
- View Article
- Google Scholar
45. Rodrigues OR, Marques C, Soares-Clemente M, Ferronha MH, Santos-Gomes GM (2009) Identification of regulatory T cells during experimental Leishmania infantum infection. Immunobiology 214: 101–111.
- View Article
- Google Scholar
46. Martin S, Pahari S, Sudan R, Saha B (2010) CD40 signaling in CD8⁺CD40⁺ T cells turns on contra-T regulatory cell functions. J Immunol 184: 5510–5518.
- View Article
- Google Scholar
47. Stäger S, Maroof A, Zubairi S, Sanos SL, Kopf M, et al. (2006) Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells. Eur J Immunol 36: 1–8.
- View Article
- Google Scholar
48. Horwitz DA, Zheng SG, Wang J, Gray JD (2008) Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3⁺CD4⁺ Treg. Eur J Immunol 38: 912–915.
- View Article
- Google Scholar
49. Wilson ME, Young BM, Davidson BL, Mente KA, McGowan SE (1998) The importance of TGF-beta in murine visceral leishmaniasis. J Immunol 161: 6148–6155.
- View Article
- Google Scholar

[ref1] 1. Saridomichelakis MN (2009) Advances in the pathogenesis of canine leishmaniosis: epidemiologic and diagnostic implications. Vet Dermatol 20: 471–489.
View Article
Google Scholar

[2] View Article

[3] Google Scholar

[ref2] 2. Antinori S, Cascio A, Parravicini C, Bianchi R, Corbellino M (2008) Leishmaniasis among organ transplant recipients. Lancet Infect Dis 8: 191–199.
View Article
Google Scholar

[5] View Article

[6] Google Scholar

[ref3] 3. Desjeux P (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27: 305–318.
View Article
Google Scholar

[8] View Article

[9] Google Scholar

[ref4] 4. WHO (2010) Control of the Leishmaniases: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22–26 March 2010.186pp.

[ref5] 5. Anstead GM, Chandrasekar B, Zhao W, Yang J, Perez LE, et al. (2001) Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection. Infect Immun 69: 4709–4718.
View Article
Google Scholar

[12] View Article

[13] Google Scholar

[ref6] 6. Malafaia G (2009) Protein-energy malnutrition as a risk factor for visceral leishmaniasis: a review. Parasite Immunol 31: 587–596.
View Article
Google Scholar

[15] View Article

[16] Google Scholar

[ref7] 7. Fernández-Guerrero ML, Robles P, Rivas P, Mójer F, Muñíz G, et al. (2004) Visceral leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosis. Acta Trop 90: 11–16.
View Article
Google Scholar

[18] View Article

[19] Google Scholar

[ref8] 8. Kaye PM, Svensson M, Ato M, Maroof A, Polley R, et al. (2004) The immunopathology of experimental visceral leishmaniasis. Immunol Rev 201: 239–253.
View Article
Google Scholar

[21] View Article

[22] Google Scholar

[ref9] 9. Miyawaki S, Nakamura Y, Suzuka H, Koba M, Yasumizu R, et al. (1994) A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice. Eur J Immunol 24: 429–434.
View Article
Google Scholar

[24] View Article

[25] Google Scholar

[ref10] 10. Shinkura R, Kitada K, Matsuda F, Tashiro K, Ikuta K, et al. (1999) Alymphoplasia is caused by a point mutation in the mouse gene encoding NF-kappa B-inducing kinase. Nat Genet 22: 74–77.
View Article
Google Scholar

[27] View Article

[28] Google Scholar

[ref11] 11. Karrer U, Althage A, Odermatt B, Roberts CW, Korsmeyer SJ, et al. (1997) On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hox11(−)/−) mutant mice. J Exp Med 185: 2157–2170.
View Article
Google Scholar

[30] View Article

[31] Google Scholar

[ref12] 12. Nishikawa S, Nakane A (1998) Host resistance against Listeria monocytogenes is reciprocal during the course of infection in alymphoplastic aly mutant mice. Cell Immunol 187: 88–94.
View Article
Google Scholar

[33] View Article

[34] Google Scholar

[ref13] 13. Yogi Y, Endoh M, Banba T, Okamura H, Nomaguchi H (1998) Susceptibility to Mycobacterium leprae of ALY (alymphoplasia) mice and IFN-gamma induction in the culture supernatant of spleen cells. Int J Lepr Other Mycobact Dis 66: 464–474.
View Article
Google Scholar

[36] View Article

[37] Google Scholar

[ref14] 14. Nitta T, Tanaka M, Sun B, Sugihara E, Kimura M, et al. (2008) Reduction of human T-cell leukemia virus type-1 infection in mice lacking nuclear factor-kappaB-inducing kinase. Cancer Sci 99: 872–878.
View Article
Google Scholar

[39] View Article

[40] Google Scholar

[ref15] 15. Engwerda CR, Ato M, Kaye PM (2004) Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis. Trends Parasitol 20: 524–530.
View Article
Google Scholar

[42] View Article

[43] Google Scholar

[ref16] 16. Engwerda CR, Kaye PM (2000) Organ-specific immune responses associated with infectious disease. Immunol Today 21: 73–78.
View Article
Google Scholar

[45] View Article

[46] Google Scholar

[ref17] 17. Stanley AC, Engwerda CR (2007) Balancing immunity and pathology in visceral leishmaniasis. Immunol Cell Biol 85: 138–147.
View Article
Google Scholar

[48] View Article

[49] Google Scholar

[ref18] 18. Murray HW (2001) Tissue granuloma structure-function in experimental visceral leishmaniasis. Int J Exp Pathol 82: 249–267.
View Article
Google Scholar

[51] View Article

[52] Google Scholar

[ref19] 19. Murray HW, Hariprashad J, Fichtl RE (1996) Models of relapse of experimental visceral leishmaniasis. J Infect Dis 173: 1041–1043.
View Article
Google Scholar

[54] View Article

[55] Google Scholar

[ref20] 20. Murray HW, Squires KE, Miralles CD, Stoeckle MY, Granger AM, et al. (1992) Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity. J Immunol 148: 1858–1863.
View Article
Google Scholar

[57] View Article

[58] Google Scholar

[ref21] 21. Oghumu S, Lezama-Dávila CM, Isaac-Márquez AP, Satoskar AR (2010) Role of chemokines in regulation of immunity against leishmaniasis. Exp Parasitol 126: 389–396.
View Article
Google Scholar

[60] View Article

[61] Google Scholar

[ref22] 22. Katakura K, Kobayashi A (1988) Acid phosphatase activity of virulent and avirulent clones of Leishmania donovani promastigotes. Infect Immun 56: 2856–2860.
View Article
Google Scholar

[63] View Article

[64] Google Scholar

[ref23] 23. Engwerda CR, Ato M, Stäger S, Alexander CE, Stanley AC, et al. (2004) Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection. Am J Pathol 165: 2123–2133.
View Article
Google Scholar

[66] View Article

[67] Google Scholar

[ref24] 24. Bretagne S, Durand R, Olivi M, Garin JF, Sulahian A, et al. (2001) Real-time PCR as a new tool for quantifying Leishmania infantum in liver in infected mice. Clin Diagn Lab Immunol 8: 828–831.
View Article
Google Scholar

[69] View Article

[70] Google Scholar

[ref25] 25. Tupperwar N, Vineeth V, Rath S, Vaidya T (2008) Development of a real-time polymerase chain reaction assay for the quantification of Leishmania species and the monitoring of systemic distribution of the pathogen. Diagn Microbiol Infect Dis 61: 23–30.
View Article
Google Scholar

[72] View Article

[73] Google Scholar

[ref26] 26. Kawamura Y, Yoshikawa I, Katakura K (2010) Imported leishmaniasis in dogs, US military bases, Japan. Emerg Infect Dis 16: 2017–2019.
View Article
Google Scholar

[75] View Article

[76] Google Scholar

[ref27] 27. Watarai H, Nakagawa R, Omori-Miyake M, Dashtsoodol N, Taniguchi M (2008) Methods for detection, isolation and culture of mouse and human invariant NKT cells. Nat Protoc 3: 70–78.
View Article
Google Scholar

[78] View Article

[79] Google Scholar

[ref28] 28. Ichii O, Kamikawa A, Otsuka S, Hashimoto Y, Sasaki N, et al. (2010) Overexpression of interferon-activated gene 202 (Ifi202) correlates with the progression of autoimmune glomerulonephritis associated with the MRL chromosome 1. Lupus 19: 897–905.
View Article
Google Scholar

[81] View Article

[82] Google Scholar

[ref29] 29. Overbergh L, Giulietti A, Valckx D, Decallonne R, Bouillon R, et al. (2003) The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 14: 33–43.
View Article
Google Scholar

[84] View Article

[85] Google Scholar

[ref30] 30. Hori S, Takahashi T, Sakaguchi S (2003) Control of autoimmunity by naturally arising regulatory CD4⁺ T cells. Adv Immunol 81: 331–371.
View Article
Google Scholar

[87] View Article

[88] Google Scholar

[ref31] 31. Bogdan C (2008) Mechanisms and consequences of persistence of intracellular pathogens: leishmaniasis as an example. Cell Microbiol 10: 1221–1234.
View Article
Google Scholar

[90] View Article

[91] Google Scholar

[ref32] 32. Greter M, Hofmann J, Becher B (2009) Neo-lymphoid aggregates in the adult liver can initiate potent cell-mediated immunity. PLoS Biol 7: e1000109.
View Article
Google Scholar

[93] View Article

[94] Google Scholar

[ref33] 33. Belkaid Y (2007) Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol 7: 875–888.
View Article
Google Scholar

[96] View Article

[97] Google Scholar

[ref34] 34. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T (2009) Regulatory T cells: how do they suppress immune responses? Int Immunol 21: 1105–1111.
View Article
Google Scholar

[99] View Article

[100] Google Scholar

[ref35] 35. Tamura C, Nakazawa M, Kasahara M, Hotta C, Yoshinari M, et al. (2006) Impaired function of dendritic cells in alymphoplasia (aly/aly) mice for expansion of CD25⁺CD4⁺ regulatory T cells. Autoimmunity 39: 445–453.
View Article
Google Scholar

[102] View Article

[103] Google Scholar

[ref36] 36. Yamada T, Mitani T, Yorita K, Uchida D, Matsushima A, et al. (2000) Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-kappa B-inducing kinase. J Immunol 165: 804–812.
View Article
Google Scholar

[105] View Article

[106] Google Scholar

[ref37] 37. Li Y, Liu S, Margolin K, Hwu P (2009) Summary of the primer on tumor immunology and the biological therapy of cancer. J Transl Med 7: 11.
View Article
Google Scholar

[108] View Article

[109] Google Scholar

[ref38] 38. Teng MWL, Swann JB, von Scheidt B, Sharkey J, Zerafa N, et al. (2010) Multiple antitumor mechanisms downstream of prophylactic regulatory T-cell depletion. Cancer Res 70: 2665–2674.
View Article
Google Scholar

[111] View Article

[112] Google Scholar

[ref39] 39. Yamaguchi T, Hirota K, Nagahama K, Ohkawa K, Takahashi T, et al. (2007) Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity 27: 145–159.
View Article
Google Scholar

[114] View Article

[115] Google Scholar

[ref40] 40. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL (2002) CD4⁺CD25⁺ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502–507.
View Article
Google Scholar

[117] View Article

[118] Google Scholar

[ref41] 41. Belkaid Y (2003) The role of CD4(+)CD25(+) regulatory T cells in Leishmania infection. Expert Opin Biol Ther 3: 875–885.
View Article
Google Scholar

[120] View Article

[121] Google Scholar

[ref42] 42. Ji J, Masterson J, Sun J, Soong L (2005) CD4⁺CD25⁺ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection. J Immunol 174: 7147–7153.
View Article
Google Scholar

[123] View Article

[124] Google Scholar

[ref43] 43. Campanelli AP, Roselino AM, Cavassani KA, Pereira MS, Mortara RA, et al. (2006) CD4⁺CD25⁺ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J Infect Dis 193: 1313–1322.
View Article
Google Scholar

[126] View Article

[127] Google Scholar

[ref44] 44. Nylén S, Maurya R, Eidsmo L, Manandhar KD, Sundar S, et al. (2007) Splenic accumulation of IL-10 mRNA in T cells distinct from CD4⁺CD25⁺ (Foxp3) regulatory T cells in human visceral leishmaniasis. J Exp Med 204: 805–817.
View Article
Google Scholar

[129] View Article

[130] Google Scholar

[ref45] 45. Rodrigues OR, Marques C, Soares-Clemente M, Ferronha MH, Santos-Gomes GM (2009) Identification of regulatory T cells during experimental Leishmania infantum infection. Immunobiology 214: 101–111.
View Article
Google Scholar

[132] View Article

[133] Google Scholar

[ref46] 46. Martin S, Pahari S, Sudan R, Saha B (2010) CD40 signaling in CD8⁺CD40⁺ T cells turns on contra-T regulatory cell functions. J Immunol 184: 5510–5518.
View Article
Google Scholar

[135] View Article

[136] Google Scholar

[ref47] 47. Stäger S, Maroof A, Zubairi S, Sanos SL, Kopf M, et al. (2006) Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells. Eur J Immunol 36: 1–8.
View Article
Google Scholar

[138] View Article

[139] Google Scholar

[ref48] 48. Horwitz DA, Zheng SG, Wang J, Gray JD (2008) Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3⁺CD4⁺ Treg. Eur J Immunol 38: 912–915.
View Article
Google Scholar

[141] View Article

[142] Google Scholar

[ref49] 49. Wilson ME, Young BM, Davidson BL, Mente KA, McGowan SE (1998) The importance of TGF-beta in murine visceral leishmaniasis. J Immunol 161: 6148–6155.
View Article
Google Scholar

[144] View Article

[145] Google Scholar

Involvement of CD4⁺ Foxp3⁺ Regulatory T Cells in Persistence of Leishmania donovani in the Liver of Alymphoplastic aly/aly Mice

Involvement of CD4⁺ Foxp3⁺ Regulatory T Cells in Persistence of Leishmania donovani in the Liver of Alymphoplastic aly/aly Mice

Figures

Abstract

Author Summary

Introduction

Materials and Methods

Mice, Parasites and Infection

Ethics Statement

Determination of Parasite Burdens by LDU in the Liver and qPCR in Different Tissues

Histopathological Analysis of Infected Foci in the Liver

Determination of Foxp3-expressing T Cells by Flow Cytometry

Determination of Foxp3-expressing Cells and T Cells by Immunohistochemistry

Double Immunofluorescence Analysis

Laser Microdissection, RNA Purification and qRT-PCR

Inhibition of CD4⁺ Foxp3⁺ Treg Function

Statistics

Results

Long-term Persistence of L. donovani in the Liver of aly/aly Mice

Delayed and Impaired Hepatic Granuloma Maturation in aly/aly Mice During L. donovani Infection

Expansion of CD4⁺Foxp3⁺ Tregs in the Liver of aly/aly Mice During Persistent L. donovani Infection

Presence of Foxp3⁺ Tregs Inside Granulomas and Perivascular Neo-lymphoid Areas in the L. donovani-infected liver of aly/aly Mice

Association of Foxp3 and IL-10 mRNA Expression in “Mature Granulomas”

Enhanced Effector Immune Responses and Declined Parasite Burden in the Liver After Inhibition of Treg Function in L. donovani-infected aly/aly Mice

Discussion

Supporting Information

Figure S1.

Figure S2.

Figure S3.

Table S1.

Acknowledgments

Author Contributions

References

Figures

Abstract

Author Summary

Introduction

Materials and Methods

Mice, Parasites and Infection

Ethics Statement

Determination of Parasite Burdens by LDU in the Liver and qPCR in Different Tissues

Histopathological Analysis of Infected Foci in the Liver

Determination of Foxp3-expressing T Cells by Flow Cytometry

Determination of Foxp3-expressing Cells and T Cells by Immunohistochemistry

Double Immunofluorescence Analysis

Laser Microdissection, RNA Purification and qRT-PCR

Inhibition of CD4+ Foxp3+ Treg Function

Statistics

Results

Long-term Persistence of L. donovani in the Liver of aly/aly Mice

Delayed and Impaired Hepatic Granuloma Maturation in aly/aly Mice During L. donovani Infection

Expansion of CD4+Foxp3+ Tregs in the Liver of aly/aly Mice During Persistent L. donovani Infection

Presence of Foxp3+ Tregs Inside Granulomas and Perivascular Neo-lymphoid Areas in the L. donovani-infected liver of aly/aly Mice

Association of Foxp3 and IL-10 mRNA Expression in “Mature Granulomas”

Enhanced Effector Immune Responses and Declined Parasite Burden in the Liver After Inhibition of Treg Function in L. donovani-infected aly/aly Mice

Discussion

Supporting Information

Figure S1.

Figure S2.

Figure S3.

Table S1.

Acknowledgments

Author Contributions

References

Inhibition of CD4⁺ Foxp3⁺ Treg Function

Expansion of CD4⁺Foxp3⁺ Tregs in the Liver of aly/aly Mice During Persistent L. donovani Infection

Presence of Foxp3⁺ Tregs Inside Granulomas and Perivascular Neo-lymphoid Areas in the L. donovani-infected liver of aly/aly Mice